ESR2: Estrogen receptor beta
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Nuclear hormone receptor.
- Drugs that act on it: 8
- With a US drug page: 3
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Chlorotrianisene | Approved | Estrogen receptor beta modulator | Modulator | — |
| Estramustine phosphate | Approved | Estrogen receptor beta modulator | Modulator | — |
| Raloxifene | Approved | Estrogen receptor beta modulator | Modulator | Boxed warning |
| AUS-131 | — | Estrogen receptor beta agonist | Agonist | — |
| CR 1447 | — | Estrogen receptor beta agonist | Agonist | — |
| Erteberel | — | Estrogen receptor beta agonist | Agonist | — |
| MF101 | — | Estrogen receptor beta agonist | Agonist | — |
| Prinaberel | — | Estrogen receptor beta agonist | Agonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Breast cancer
- 0.62
- Osteoporosis
- 0.61
- Postmenopausal osteoporosis
- 0.58
- Menopause
- 0.57
- Dyspareunia
- 0.56
- Atrophy
- 0.55
- Neoplasm
- 0.49
- Breast carcinoma
- 0.49
- Hypogonadism
- 0.47
- Primary ovarian failure
- 0.47
- Atrophic Vaginitis
- 0.47
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- ESR2
- Related
- Estrogen receptor
Drugs and mechanisms are from ChEMBL CHEMBL242 (CC BY-SA 3.0). Gene name, function (UniProt Q92731, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets